Cardiac device patients who are not adherent with remote monitor transmissions will miss out on the following benefits:
The MyCareLink Heart™ mobile app results in 94.6% patient adherence to transmission schedule compared to 77% patient adherence for bedside monitors.7
A 2019 call characterization study8 shows that 40% of device clinical call burden is due to patient calls surrounding four recurring issues. The MyCareLink Heart mobile app is the patient monitor designed to help address these four categories that drive 40% of all clinical call burden.
1. Transmission status
The MyCareLink Heart mobile app states in clear language the status of each transmission and allows patients to send a device transmission to their HCP if required.
2. Connectivity issues
The MyCareLink Heart mobile app allows patients the opportunity to check on their connectivity any time, day or night.
3. Disconnected app follow-up
The MyCareLink Heart mobile app tells patients not to disconnect but reminds them to reconnect if they do.
4. Patient education
The MyCareLink Heart mobile app offers answers to patients’ most frequently asked questions.
Clinicians spend hours per week handling calls from patients on monitors due to:
The Stay Connected service is designed to be every patient’s first point of contact for assistance with:
Providing support can help reduce the time patients spend unmonitored due to monitor issues, freeing up time for clinicians to focus on care.
The AccuRhythm AI platform is an artificial intelligence system that applies deep learning algorithms to LINQ II insertable cardiac monitor (ICM) data flowing into the CareLink™ network. The algorithms address the two most common sources of ICM false alerts — atrial fibrillation (AF) and pause.11-13
AccuRhythm AI algorithms can save clinicians approximately 319 hours of false alert review yearly for every 200 LINQ II ICM patients.*14
The Paceart Optima system is a comprehensive clinic workflow solution used to efficiently compile and manage patients’ cardiac device data across manufacturers while improving patient care, clinic efficiency, and clinic economics.
Learn more about Paceart Optima system features and benefits.
Saxon LA, Hayes DL, Gilliam FR, et al. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation. December 7, 2010;122(23):2359-2367.
Varma N, Piccini JP, Snell J, Fischer A, Dalal N, Mittal S. The Relationship between Level of Adherence to Automatic Wireless Remote Monitoring and Survival in Pacemaker and Defibrillator Patients. J Am Coll Cardiol. June 23, 2015;65(24):2601-2610.
Akar JG, Bao H, Jones PW, et al. Use of Remote Monitoring is Associated with Lower Risk of Adverse Outcomes Among Patients with Implanted Cardiac Defibrillators. Circ Arrhythm Electrophysiol. October 2015;8(5):1173-1180.
Cronin EM, Ching EA, Varma N, Martin DO, Wilkoff BL, Lindsay BD. Remote monitoring of cardiovascular devices: a time and activity analysis. Heart Rhythm. December 2012;9(12):1947-1951.
Varma N. Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study. Am Heart J. December 2007;154(6):1029-1034.
Crossley GH, Boyle A, Vitense H, Chang Y, Mead RH; CONNECT Investigators. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol. March 8, 2011;57(10):1181-1189.
Tarakji KG, Zaidi AM, Zweibel SL, et al. Performance of First in the World Pacemaker to Use Smart Device App for Remote Monitoring. Late-breaking clinical trial presented online at HRS 2020.
Van Heel L, Seiler A, Cirocco T, et al. Abstract 11847: Characterization of Patient Calls at Cardiac Device Clinics: Economic Implications and Opportunities for Improved Efficiency. Circulation. November 11, 2019;140:A11847.
Of patients responding to survey. MyCareLink Heart patient satisfaction. Medtronic data on file. February 2021.
Stay Connected Patient Satisfaction Rate and Resolution Rate. Medtronic data on file. May 2020.
Cheng YJ, Ousdigian KT, Koehler J, Cho YK, Kloosterman M. Innovative Artificial Intelligence Application Reduces False Pause Alerts while Maintaining Perfect True Pause Sensitivity for Insertable Cardiac Monitors. Presented at Heart Rhythm Society Conference 2021. Published online August 1, 2021.
Radtke A, Ousdigian KT, Haddad TD, Koehler JL, Colombowala IK. Artificial Intelligence Enables Dramatic Reduction of False Atrial Fibrillation Alerts from Insertable Cardiac Monitors. Presented at Heart Rhythm Society Conference 2021.
AccuRhythm Clinician Manual Supplements M015316C001 and M015314C001.
Ousdigian K, Cheng YJ, Koehler J, Radtke A, Rosemas S, Rogers J. Artificial Intelligence Dramatically Reduces Annual False Alerts from Insertable Cardiac Monitors. Presented at American Heart Association Conference, November 2021.
Seiler A, Biundo E, Di Bacco et al. Clinic Time Required for Remote and In-Person Management of Patients With Cardiac Devices: Time and Motion Workflow Evaluation. JMIR Cardio. October 15, 2021;5(2):e27720.
Clinic Case Study: CentraCare Heart & Vascular Center Case Study: A Central System for Improved Patient Care. Medtronic data on file. April 2017.